Breaking News

Investing

CEN Biotech CEO Funds Company, Forgives $2 Million Debt – Updated

CEN Biotech Inc, a wholly owned Canadian subsidiary of the hotly debated publicly traded company Creative edge nutrition (OTC: FITX) which is actively engaged in seeking a licence to grow marijuana under Canada’s newly formed MMPR, filed it’s quarterly financials last week on the OTC markets. Both the company and it’s CEO, Dr. Bill Chaaban, who is a licensed attorney in both …

Read More »

MMPR Producer Health Check, Organigram

OrganiGram How successful are current licensed producers under Canada’s Medical Marijuana Program? Health Canada seems to have a growing concern under its Marijuana programs and how viable these companies actually are. While it is not my intention to report negative findings of any particular company, I believe it’s important to understand or at least shed some light on Health Canada’s …

Read More »

Distortion and Cyber-terrorism – Canadian Medical Marijuana Company Targeted

Collaboration: from the Latin word collaboratus, a past participle of collaborare “to labor together”, from Latin com- + laborare to labor. In a letter dated January 13th, 2014 from the Licences and Permits Division of Health Canada’s Office of Controlled Substances, CEN Biotechs CEO, Mr. Bill Chaaban is personally thanked for his collaboration with Health Canada through the licensing process …

Read More »

Health Canada Faces Quality Control Issues Under MMPR

Health Canada faces quality control issues in the delivery of product from companies operating under the MMPR (Marijuana for Medical Purposes Regulations). In a recent surprise move by the IIROC, Aphria a publicly traded company, was suspended from trading on March 31, 2015. Aphria trades on the TSX-Venture markets in Canada under the symbol APH.V. The halt resulted from what …

Read More »

CEN Biotech Files Application for Judicial Review – UPDATED

UPDATED: CEN Biotech Files Application for Judicial Review and is seeking discovery. Health Canada Has 10 days to oppose Mandamus or issue a license under MMRP CEN Biotech and other applicants treated unfairly CEN Biotech requested to accelerate build out, receiving no license CEN Biotech Inc. has filed application for judicial review through the federal courts in Ontario against the …

Read More »

Work Hard In Silence

“Work hard in silence, and let your success make the noise” is the most apt quote that comes to mind when we consider the patience of investors throughout CEN Biotech’s 90 day Quiet Period, ending shortly on Feb. 17th 2015. In the face of bashers and their misplaced skepticism, CEN Biotech will soon be making another strategicallyok well-timed spin off …

Read More »

CEN Biotech Shows Strong Uptrend

www.flickr.com/photos/ox4photos/5607206237/

CEN Biotech shows strong uptrend despite attempts by detractors to confuse new investors. Last week, following some very positive news about the direction that Creative Edge Nutrition (ticker Symbol FITX) is taking from new CEO James Robinson, the company gained more then 100% in its stock price. There was also mention of an updated website that will make it’s appearance …

Read More »

TWEED Profit Overview TWD.V (TWMJF)

Tweed is a licensed producer in Canada that is operating two licenses to grow medical marijuana under the MMPR program. The purpose of this article is to measure the efficiency of Tweed to generate income and how it controls its operating costs and expenses. As I will show Tweed is having difficulty in actually turning a profit. Contrary to the …

Read More »

Terra Tech Corp (TRTC) – Is Terra Tech Insolvent?

Note: this article has been revised. Financial ratios are a mathematical means of comparing and deducing the overall health of a company internally. It helps highlight areas within the company that are doing well or areas within the company that are doing poorly. This often helps financial analysts, creditors, and even internal management determine the stability or instability of the business …

Read More »

Cen Biotech Earnings Analysis

Investors Impressed with CEN Biotech Financials Financial reports are SEC disclosures that provide nominal information regarding a company’s earnings expectations, current financial standing, revenue, and most importantly, transparent financial decisions important to the structural framework of a firm.  There has been much speculation and anticipation towards the financial statements (ending Sept 30th 2014) of CEN Biotech, posted on January 13th …

Read More »